Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.96 | 35.37 |
| PEG Ratio (TTM) | 0.00 | 2.14 |
| P/S Ratio (TTM) | 1.84 | 3.97 |
| P/B Ratio (TTM) | 0.18 | 7.11 |
| P/FCF Ratio (TTM) | 1.16 | 22.53 |
| Price to 5YR AVG Earnings Ratio | N/A | 36.05 |
| Price to 5YR AVG FCF Ratio | N/A | 27.60 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -18.39% | 6.24% |
| ROE (TTM) | -32.29% | 21.24% |
| Net Profit Margin (TTM) | -158.67% | 10.56% |
| ROIC 5YR AVG | N/A | 19.22% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -12.65% | 1,377.86% | N/A |
| Revenue | -20.40% | 254.62% | N/A |
| Net Income | 43.59% | 163.61% | N/A |
| Cash Flow | 498.51% | 353.73% | N/A |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 44.63 | 1.71 |
| Quick Ratio (TTM) | 44.63 | 1.71 |
| D/E Ratio (TTM) | N/A | 1.09 |
| Interest Coverage (TTM) | N/A | 29.53 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.96 | 5.27 |
| LTL to 5YR AVG FCF | N/A | 3.77 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.53% |